Filter
1657
Text search:
molecular
Featured
208
294
Language
Document type
642
390
326
111
78
50
27
12
11
7
1
1
1
Countries
95
66
63
53
51
41
36
28
28
25
23
21
17
17
15
15
14
14
14
14
13
12
12
12
11
11
11
11
10
10
10
10
10
9
9
8
7
7
7
7
7
7
7
7
7
6
6
6
6
5
5
5
5
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
556
195
75
71
32
18
12
Toolboxes
339
245
152
104
79
55
50
43
39
35
32
32
31
26
15
13
11
11
10
8
7
6
5
4
TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
TB policies in 24 Countries
A survey of prevention, testing and treatment policies and practices
Лечение туберкулеза в 24 странах
Исследование диагностической и клинической практики
Lancet Respir Med 2017; 5: 291–360Vol, 5 April 2017
Update 2021; Immunization, Vaccines and Biologicals
Ciudad de México, México - 26 al 28 de mayo del 2014
Elaborat în cadrul proiectului „Fortificarea controlului tuberculozei în Moldova”, finanţat de către
Fondul Global de combatere a SIDA, Tuberculozei şi Malariei.
15. Euro Surveill. 2017;22(47):pii=17-00103
Chapter 2 in "Latest Findings in Intellectual and Developmental Disabilities Research" Edited by Üner Tan, ISBN 978-953-307-865-6, 404 pages, Publisher: InTech, Chapters published February 15, 2012 under CC BY 3.0 license | Intellectual and Developmental Disabilities presents reports on a wide rang
...
J Pediatr Rev 2015, vol.3 (1) e361
Estas Normas pretendem ser um instrumento de apoio ao profissional
de saúde afecto às Unidades Sanitárias, à todos os níveis de atenção de
saúde para o diagnóstico, tratamento e seguimento da HTA, bem como
prevenção das complicações
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
